[Form 4] Morgan Stanley Insider Trading Activity

Rhea-AI Filing Summary

Form 4 filing overview:

• Reporting person: Lynn J. Good, independent director.
• Date of transaction: 01-Aug-2025.
• Securities involved: 1,658.438 deferred stock units (DSUs) that convert 1-for-1 into Morgan Stanley (MS) common stock.
• Transaction code: A – automatic acquisition under the Directors' Equity Capital Accumulation Plan; cash price: $0.
• Ownership after grant: 1,658.438 shares held directly.

The filing reflects a routine equity award for board service rather than an open-market purchase. Given Morgan Stanley’s multi-billion-share float, the grant is immaterial to valuation or insider-sentiment analysis. No derivative positions, sales, or 10b5-1 plan indications were reported.

Insights

Securities Analyst

TL;DR: Small automatic DSU grant to director; immaterial to MS fundamentals or trading outlook.

The 1,658-share award represents less than 0.0001% of Morgan Stanley’s outstanding shares. It is standard board compensation, executed at $0 under the Director Equity Plan. No open-market buying signal and no sale pressure indicated. From a valuation or sentiment standpoint, the event is neutral; investors should focus instead on upcoming earnings, capital ratios, and wealth-management inflows.

Corporate Governance Specialist

TL;DR: Routine equity alignment; governance status unchanged.

Issuing DSUs aligns directors with shareholder interests by tying compensation to stock performance, a governance best practice. However, the modest size means limited incentive shift. Absence of a 10b5-1 designation implies discretionary timing but, given automatic plan nature, raises no red flags. Overall, the filing neither enhances nor detracts from MS’s governance profile.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOOD LYNN J

(Last) (First) (Middle)

1585 BROADWAY

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MORGAN STANLEY [ MS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2025		A(1)		1,658.438	A	$0	1,658.438	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units granted under the Morgan Stanley Directors' Equity Capital Accumulation Plan, which are convertible into shares of Common Stock at a ratio of 1 to 1.

Remarks:

	/s/ Martin M. Cohen, Attorney-in-Fact	08/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.